# Testosterone and Neurovascular Control in Humans

> **NCT04819204** · NA · UNKNOWN · sponsor: **Western University, Canada** · enrollment: 20 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Cetrorelix Acetate
- **DRUG:** Testosterone gel

## Key facts

- **NCT ID:** NCT04819204
- **Lead sponsor:** Western University, Canada
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04819204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04819204, "Testosterone and Neurovascular Control in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04819204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
